Scott B Vafai
Overview
Explore the profile of Scott B Vafai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
2082
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Girnun G, Chen L, Silvaggi J, Drapkin R, Chirieac L, Padera R, et al.
Clin Cancer Res
. 2008 Oct;
14(20):6478-86.
PMID: 18927287
Purpose: Current therapy for lung cancer involves multimodality therapies. However, many patients are either refractory to therapy or develop drug resistance. KRAS and epidermal growth factor receptor (EGFR) mutations represent...
12.
Pagliarini D, Calvo S, Chang B, Sheth S, Vafai S, Ong S, et al.
Cell
. 2008 Jul;
134(1):112-23.
PMID: 18614015
Mitochondria are complex organelles whose dysfunction underlies a broad spectrum of human diseases. Identifying all of the proteins resident in this organelle and understanding how they integrate into pathways represent...
13.
Girnun G, Naseri E, Vafai S, Qu L, Szwaya J, Bronson R, et al.
Cancer Cell
. 2007 May;
11(5):395-406.
PMID: 17482130
PPARgamma is a member of the nuclear receptor family for which agonist ligands have antigrowth effects. However, clinical studies using PPARgamma ligands as a monotherapy failed to show a beneficial...
14.
Vafai S, Stock J
FEBS Lett
. 2002 May;
518(1-3):1-4.
PMID: 11997007
Tau hyperphosphorylation is a central event in the development of Alzheimer's Disease (AD). Protein phosphatase 2A (PP2A) heterotrimer formation is necessary for efficient dephosphorylation of the tau protein. S-Adenosylmethionine-dependent carboxyl...